Rita Koester, MD | |
9040 Jackson Avenue, Tacoma, WA 98431-1303 | |
(253) 982-9154 | |
Not Available |
Full Name | Rita Koester |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 9040 Jackson Avenue, Tacoma, Washington |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528038460 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | MD00025527 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rita Koester, MD 9040 Jackson Avenue, Tacoma, WA 98431-0001 Ph: (253) 982-9154 | Rita Koester, MD 9040 Jackson Avenue, Tacoma, WA 98431-1303 Ph: (253) 982-9154 |
News Archive
In laboratory experiments, a metabolic inhibitor was able to kill a variety of human cancer cells of the skin, breast, lung, cervix and soft tissues through a non-apoptotic route - catastrophic macropinocytosis.
A new study recently published on the medRxiv* preprint server demonstrates the use of a serological testing algorithm for identifying disparities in infection rates and vaccine uptake amongst the study population to enable public health interventions.
The key to immune-based cancer therapies lies in the ability to exploit some weakness within the tumor and its environment or to elude cancer's offenses. Writing in the journal Scientific Reports, researchers led by a group from the Roswell Park Cancer Institute Center for Immunotherapy have shared new insights about a subset of T cells that appear to do both those things, inhibiting cancer growth at the same time that they enhance the tumor-killing powers of other immune cells.
Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company, and Ipsen, a global biotechnology specialty care group, announced today that the two companies have entered into an exclusive research collaboration agreement to leverage their expertise in Dicer Substrate siRNA (DsiRNA) research and peptide engineering. The companies will develop novel conjugates of Dicerna's DsiRNA molecules and Ipsen's peptide targeting vectors in the therapeutic areas of oncology and endocrinology.
› Verified 9 days ago
David Lee Robinson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-2252 | |
Nan Shin, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1112 S Cushman Ave, Tacoma, WA 98405 Phone: 253-593-2144 Fax: 253-280-9881 | |
Arthur L Walter, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Pediatric Extended Care Clinic, Madigan Army Medical Center, Tacoma, WA 98431 Phone: 253-968-3066 | |
Bradley Stanton Hood, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 311 S L St, Tacoma, WA 98405 Phone: 253-403-1540 | |
Kirk N. Liesemer, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-3066 | |
Christopher Anthony Bellotti, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 603 S J St Ste 102, Tacoma, WA 98405 Phone: 253-396-4868 Fax: 253-396-4870 | |
Dr. Michael Timothy Alston, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 |